Tarsus Pharmaceuticals (TARS) Amortizatization of Intangibles (2023 - 2026)
Tarsus Pharmaceuticals' Amortizatization of Intangibles came in at $200,000 for Q2 2026, unchanged from $200,000 a year earlier and down 16.7% from the prior quarter.
Powered by 
Analysis
Tarsus Pharmaceuticals (TARS) Amortizatization of Intangibles (2023 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Tarsus Pharmaceuticals reported Amortizatization of Intangibles of $920,000, up 17.9% year-over-year; for FY2025, it came in at $1 million, up 85.2% from FY2024.
- Going back by year, Amortizatization of Intangibles was $540,000 in FY2024 (+306.0%) and $133,000 in FY2023.
- The five-year range for quarterly Amortizatization of Intangibles is $100,000 (Q4 2023) to $280,000 (Q4 2025).
- Year-over-year, Amortizatization of Intangibles increased in five of the last seven quarters, with growth averaging 71.0%.
- Business Quant data shows TARS's Amortizatization of Intangibles at $240,000 (Q1 2026), $280,000 (Q4 2025) and $200,000 (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amort. of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | - |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | - |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 1.70 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 984.00 Mn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | - |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | - |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | 600.00 Mn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | - |
| 10 | Tarsus Pharmaceuticals | 3.16 Bn | 2.10 Bn | 161.80 Mn | 200,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 200,000.00 |
| Mar 31, 2026 | 240,000.00 |
| Dec 31, 2025 | 280,000.00 |
| Sep 30, 2025 | 200,000.00 |
| Jun 30, 2025 | 200,000.00 |
| Mar 31, 2025 | 240,000.00 |
| Dec 31, 2024 | 240,000.00 |
| Sep 30, 2024 | 100,000.00 |
| Jun 30, 2024 | 100,000.00 |
| Mar 31, 2024 | 100,000.00 |
| Dec 31, 2023 | 100,000.00 |
API Access
Tarsus Pharmaceuticals Amortizatization of Intangibles API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=amortizatization-of-intangibles&ticker=TARS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "amortizatization-of-intangibles", "ticker": "TARS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=amortizatization-of-intangibles&ticker=TARS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();